Iron-balance and dose-response studies of the oral iron chelator 1,2- dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell disease
AF Collins(Hospital for Sick Children), NF Olivieri(Hospital for Sick Children), Marilyn Fry(Hospital for Sick Children), Dianne G. Shaw(Hospital for Sick Children), Nathan E. Lewis(University of Georgia), Douglas M. Templeton(University of Toronto), FF Fassos(Hospital for Sick Children), Gideon Koren(Rhode Island Hospital), RA McClelland(Hospital for Sick Children), S Stobie(Hospital for Sick Children)
Cited by 84
Related Papers
Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0
|Nature Protocols|2011|1.9k
Deciphering cell–cell interactions and communication from gene expression
|Nature Reviews Genetics|2020|1.3k
BiGG Models: A platform for integrating, standardizing and sharing genome-scale models
|Nucleic Acids Research|2015|1k
Omic data from evolved E. coli are consistent with computed optimal growth from genome‐scale models
|Molecular Systems Biology|2010|826
Constraining the metabolic genotype–phenotype relationship using a phylogeny of in silico methods
|Nature Reviews Microbiology|2012|809